You know this trial is a double-blinded control trial right? The data doesn't get unlocked prior to complete patient enrolment and after the last time-point. This extension is not a reflection of "quality data" being seen. This (as they stated), is due to feedback from KOL's that twice weekly injections isn;t commercially appetising, hence they're trying once a week. IMO
- Forums
- ASX - By Stock
- PAR
- Ann: Phase 2 Synovial Fluid Biomarker Study Update
Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-49
-
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
25.5¢ |
Change
0.025(10.9%) |
Mkt cap ! $87.44M |
Open | High | Low | Value | Volume |
24.0¢ | 28.0¢ | 24.0¢ | $288.4K | 1.157M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 32617 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 52942 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 40374 | 0.255 |
4 | 40698 | 0.250 |
4 | 127900 | 0.245 |
6 | 251129 | 0.240 |
3 | 171803 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 52942 | 3 |
0.265 | 6544 | 2 |
0.270 | 18471 | 2 |
0.280 | 48587 | 4 |
0.285 | 28950 | 3 |
Last trade - 14.13pm 20/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |